Overview
Brian Osgood is a Hematologist Oncology specialist and a Hematologist in Kansas City, Missouri. Dr. Osgood is rated as an Experienced provider by MediFind in the treatment of Common Variable Immune Deficiency. His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Familial Prostate Cancer, Endometrial Cancer, and Desmoplastic Small Round Cell Tumor. Dr. Osgood is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1000 E 101st Terrace, Univ Ks Cncr Cntr S, Kansas City, MO 64131
201 W Rd Mize Rd, St Mary Med Center, Blue Springs, MO 64014
19600 E 39th St S, Centerpnt Med Center, Independence, MO 64057
4881 Ne Goodview Cir, Univ Ks Cncr Center, Lees Summit, MO 64064
University Of Kansas Hospital Authority
Christopher Sirridge is a Hematologist Oncology specialist and an Oncologist in Overland Park, Kansas. Dr. Sirridge is rated as a Distinguished provider by MediFind in the treatment of Common Variable Immune Deficiency. His top areas of expertise are Hereditary Resistance to Anti-Vitamin K, Congenital Antithrombin 3 Deficiency, Protein C Deficiency, and Protein S Deficiency. Dr. Sirridge is currently accepting new patients.
University Of Kansas Hospital Authority
Robert Pluenneke is a Hematologist Oncology specialist and a Hematologist in Liberty, Missouri. Dr. Pluenneke is rated as a Distinguished provider by MediFind in the treatment of Common Variable Immune Deficiency. His top areas of expertise are Testicular Yolk Sac Tumor, Virilizing Ovarian Tumor, Ovarian Carcinosarcoma, Endoscopy, and Bone Marrow Aspiration. Dr. Pluenneke is currently accepting new patients.
University Of Kansas Hospital Authority
Amy Braden is a Hematologist Oncology specialist and a Hematologist in Kansas City, Missouri. Dr. Braden is rated as an Advanced provider by MediFind in the treatment of Common Variable Immune Deficiency. Her top areas of expertise are Familial Colorectal Cancer, Inflammatory Breast Cancer, Angiosarcoma, and Anemia. Dr. Braden is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Large-Cell Immunoblastic LymphomaDr. Osgood isDistinguished. Learn about Large-Cell Immunoblastic Lymphoma.
- Advanced
- Adult Immune ThrombocytopeniaDr. Osgood isAdvanced. Learn about Adult Immune Thrombocytopenia.
- Breast CancerDr. Osgood isAdvanced. Learn about Breast Cancer.
- Chronic B-Cell Leukemia (CBCL)Dr. Osgood isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)
- Chronic Myelogenous Leukemia (CML)
- Classical Hodgkin LymphomaDr. Osgood isAdvanced. Learn about Classical Hodgkin Lymphoma.
- Experienced
- Acute Mountain SicknessDr. Osgood isExperienced. Learn about Acute Mountain Sickness.
- Adenoid Cystic CarcinomaDr. Osgood isExperienced. Learn about Adenoid Cystic Carcinoma.
- Adult Soft Tissue SarcomaDr. Osgood isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Osgood isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Osgood isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Alveolar Soft Part SarcomaDr. Osgood isExperienced. Learn about Alveolar Soft Part Sarcoma.